ForsLean® addresses overall metabolic health and not just weight management, says Mr. Shaheen Majeed, President-Worldwide, Sabinsa
At April’s SupplySide East trade show, Sabinsa Corporation explained how its branded Coleus forskohlii extract ingredient, ForsLean…
Sabinsa Awarded New Patents For ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423
Sabinsa Publishes ForsLean® Safety Data in International Journal of Pharmacy & Pharmaceutical Research
Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®
Sabinsa Introduces Softgel Ready ForsLean® Soft Extracts Amid Exponential Growth in Coleus Demand: Company Cautions Against Low Quality Spam Knockoffs
Just in time for legitimate dietary supplement manufacturers to differentiate their products from the inferior spamtouted forskolin products driven…
Sabinsa Receives Payment from Creative Compounds for ForsLean® Trademark Infringement
An intellectual property battle lasting three years and reaching the US Supreme Court has ended at last with payment to Sabinsa Corporation by Creative Compound…
Creative Compounds’ Attempt to Continue Trademark Infringement of Sabinsa’s ForsLean® Rejected by US Supreme Court
Sabinsa’s International Presence Sabinsa Corporation’s protracted battle against Creative Compounds’ trade mark infringement of Sabinsa
Sabinsa Granted Forskolin Solubility Patent in China
Sabinsa’s International Presence The State Intellectual Property Office of the People’s Republic of China has granted Sabinsa a patent entitled…
Sabinsa’s ForsLean® Gets PI Numbers From TGA To Enter Australian Market
Sabinsa Corporation has received Product Information (PI) numbers for ForsLean® 10% and 20% from Australia’s TGA (Therapeutic Goods Administration)
US Appeals Court Finds Creative Compounds Guilty of Trademark Infringement Against Sabinsa’s ForsLean®
Sabinsa’s International Presence Sabinsa Corporation has achieved a significant victory in protecting its intellectual property investment in ForsLean®…
Sabinsa Secures International Forskolin Patent: Granted in Republic of South Africa & Singapore
Sabinsa has been granted a patent in South Africa and Singapore as part of its PCT application on “Process of preparing water soluble diterpenes and their app…
Sabinsa Notifies Alchem as to Status of Its Forskolin(ForsLean®) Patent
Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin (ForsLean®), and…
Sabinsa Secures Patent For ForsLean® in Canada
Sabinsa Corporation today announced that it has secured a patent in Canada for its branded ingredient ForsLean® , a standardized extract of Coleus forskohlii…
Sabinsa Sues to Protect Its Piperine (BioPerine®) and Forskolin (ForsLean®) Patents
Sabinsa Corporation announced today that it has sued BioGreen NutraChem Inc. in the United States District Court in the Eastern District of New York for infring…
Sabinsa Successfully Protects Its Piperine (BioPerine®) and Forskolin (ForsLean®) Patents
Sabinsa Corporation announced today that it has successfully concluded its patent infringement lawsuit against DNP International, Inc. in the United States Dist…
Sabinsa Corporation is Awarded Thomas Alva Edison Patent Award
Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, was awarded…
ForsLean® Improves Body Composition According to Study Published In The Journal of Obesity Research
A recent study published in the August 2005 Journal of Obesity Research entitled “Body Composition and Hormonal Adaptations…
Sabinsa Successfully Defends Patent Infringement Lawsuit Against GCI Nutrients
Sabinsa Corporation has once again successfully protected its intellectual property (IP). Mark C. Sysler, Sabinsa’s Sr. EVP for Marketing and Sales today anno…
Sabinsa Wins ForsLean® Patent Infringement Suit Against Indfrag Ltd.
Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit th…
Sabinsa ForsLean® Now Water Soluble
Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit…
Science Behind ForsLean® Garners Best New Dietary Supplement Product of The Year Award for Sabinsa
Sami Labs, Ltd., the research and manufacturing arm of Sabinsa Corporation, was recently notified that it will be the recipient of two Export awards for the year…
US and Japanese Clinical Trials of Sabinsa’s ForsLean® for Weight Management Underway
Two new studies have been undertaken to further explore the safety and efficacy of ForsLean®, Sabinsa’s patented lean body mass promoting and weight loss…
Sabinsa Corporation Announces General Availability of ForsLean® Lean Body Mass Supplement
In an effort to assist their customers, and potential customers, to understand the scope of Patent # 5,804,596, Sabinsa Corporation requested its legal counsel…
Sabinsa Corporation Announces General Availability of ForsLean® Lean Body Mass Supplement
Sabinsa Corporation announces that its popular dietary supplement ingredient ForsLean®, a standardized extract from Coleus forskholii roots patented by Sabinsa…